Validation of a Cystic Fibrosis Co-Culture Model for the Identification of Dual Acting Compounds with Antibiotic and Antibiotic Adjuvant Properties
ACS Infectious Diseases · 2025
DOI: 10.1021/acsinfecdis.5c00226 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Infectious Diseases, 2025. Verfasst von Anne E Mattingly und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame 46556, Indiana, United States. Hauptthemen laut MEDLINE: Cystic Fibrosis, Pseudomonas aeruginosa, Anti-Bacterial Agents, Staphylococcus aureus. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, University of Notre Dame, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame 46556, Indiana, United States.
ORCID-Profile: Christian Melander
Förderung
- NIAID NIH HHS
- University of Notre Dame
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Mattingly, A. E., Li, H., Melander, R. J., & Melander, C. (2025). Validation of a Cystic Fibrosis Co-Culture Model for the Identification of Dual Acting Compounds with Antibiotic and Antibiotic Adjuvant Properties. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.5c00226
Vancouver
Mattingly AE, Li H, Melander RJ, Melander C. Validation of a Cystic Fibrosis Co-Culture Model for the Identification of Dual Acting Compounds with Antibiotic and Antibiotic Adjuvant Properties. ACS Infectious Diseases. 2025. doi:10.1021/acsinfecdis.5c00226
BibTeX
@article{Mattingly2025,
author = {Mattingly, Anne E and Li, Haoting and Melander, Roberta J and Melander, Christian},
title = {Validation of a Cystic Fibrosis Co-Culture Model for the Identification of Dual Acting Compounds with Antibiotic and Antibiotic Adjuvant Properties},
journal = {ACS Infectious Diseases},
year = {2025},
doi = {10.1021/acsinfecdis.5c00226}
}
EUVIMED